1. In accordance with section 733(d) of the Tariff Act of 1930, as amended, Commerce is instructing CBP to discontinue the suspension of liquidation of entries concerning the antidumping duty investigation of Hexamethylenetetramine from Saudi Arabia effective 11/02/2025, which is the day after provisional measures in this proceeding has been in place for 180 days. 2. The products covered by this investigation are described in message 4311402 dated 11/06/2024. 3. CBP shall discontinue the suspension of liquidation for antidumping duty purposes on all shipments of subject merchandise entered, or withdrawn from warehouse, for consumption on or after 11/02/2025 (the first day provisional measures is no longer in effect). The suspension of liquidation will not be resumed unless and until a final affirmative determination on this case is published in the Federal Register by the ITC. 4. These discontinuation instructions do not apply to subject merchandise subject to suspension of liquidation and imposition of cash deposits, entered, or withdrawn from warehouse, for consumption on or before 11/01/2025 (the date provisional measures expired in this proceeding). 5. CBP shall liquidate entries of shipments of subject merchandise entered, or withdrawn from warehouse, for consumption during the period 11/02/2025 (the first day provisional measures is no longer in effect) through 11/24/2025 without regard to antidumping duties (i.e., refund all cash deposits of antidumping duties). This message constitutes notice of lifting of suspension of liquidation of such entries. 6. The interest provisions of section 778 of the Tariff Act of 1930, as amended, do not apply. 7. If there are any questions by the public regarding this message, please contact the Call Center for the Office of AD/CVD Operations, Enforcement and Compliance, International Trade Administration, U.S. Department of Commerce at (202) 482-0984. CBP ports should submit their inquiries through authorized CBP channels only. (This message was generated by OII:CS) 8. There are no restrictions on the release of this information. Alexander Amdur